Home LiteratureArticle Details
PMID: 27468422 Published · epublish English Journal Article

The effect of parental age on the presence of de novo mutations - Lessons from neurofibromatosis type I.

Molecular genetics & genomic medicine ·Vol. 4 ·No. 4 ·2016-07-00 ·Pages 480-6

Dubov T, Toledano-Alhadef H, Bokstein F, Constantini S, Ben-Shachar S

Abstract

Neurofibromatosis type 1 (NF1) is the most common autosomal dominant neurocutaneous disease with a prevalence of 1:2500. Approximately, 50% of the cases are sporadic. Advanced paternal age is associated with germline mutations and autosomal diseases. We aimed to use NF1 as a paradigm to study the effect of parental age on sporadic mutation rates for both advanced and younger parental ages. The medical charts of 118 NF1 pediatric patients followed in a specialized Israeli NF1 clinic were evaluated. Thirty-one cases were diagnosed by genetic tests and 87 by NIH clinical criteria. Sixty-four cases (54%) had a negative family history of NF1 (sporadic cases). Data on parental ages at the time of the children's birth were compared to the national population database. Parental age of children with sporadic NF1 was higher than the general population (32.7 years vs. 30.1 years, respectively, for the mothers and 36.5 years vs. 32.6 years, respectively, for the fathers; P < 0.0001 for both groups). In contrast, the age of the mothers and the fathers in the familial cases (30.3 and 33.9 years, respectively) did not differ from the general population. Significantly, fewer fathers of the sporadic group had been 25-29 years old at their child's birth compared with fathers in the general population (7.8% vs. 21%, respectively, P = 0.009), and significantly more fathers were ≥40 years old (29.7% vs. 13.6%, respectively, P = 0.0002). Differences in maternal age between these two groups were less prominent. Parents of sporadic NF1 cases are older. The risk for sporadic NF1 was lower when the fathers were younger at the time of the affected child's birth, and gradually increased with paternal age.

Keywords
Advanced paternal age autosomal dominant de novo sporadic neurofibromatosis type 1
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Dubov Tom
Sackler Faculty of Medicine Tel-Aviv University Tel-Aviv Israel.
Toledano-Alhadef Hagit
Sackler Faculty of MedicineTel-Aviv UniversityTel-AvivIsrael; The Gilbert Israeli Neurofibromatosis CenterTel-Aviv Medical CenterTel-AvivIsrael.
Bokstein Felix
Sackler Faculty of MedicineTel-Aviv UniversityTel-AvivIsrael; The Gilbert Israeli Neurofibromatosis CenterTel-Aviv Medical CenterTel-AvivIsrael.
Constantini Shlomi
Sackler Faculty of MedicineTel-Aviv UniversityTel-AvivIsrael; The Gilbert Israeli Neurofibromatosis CenterTel-Aviv Medical CenterTel-AvivIsrael; Department of Pediatric NeurosurgeryDana Children's Hospital, Tel-Aviv Medical CenterTel-AvivIsrael.
Ben-Shachar Shay
Sackler Faculty of MedicineTel-Aviv UniversityTel-AvivIsrael; The Gilbert Israeli Neurofibromatosis CenterTel-Aviv Medical CenterTel-AvivIsrael.
References (43)
43 references, click to expand
  1. On the mutation rate of neurofibromatosis.
    Humangenetik. 1975 Jun 19;28(2):129-38 PMID: 125227
  2. Mutations in fibroblast growth-factor receptor 3 in sporadic cases of achondroplasia occur exclusively on the paternally derived chromosome.
    Am J Hum Genet. 1998 Sep;63(3):711-6 PMID: 9718331
  3. Evidence for selective advantage of pathogenic FGFR2 mutations in the male germ line.
    Science. 2003 Aug 1;301(5633):643-6 PMID: 12893942
  4. Parental age effects on the occurrence of new mutations for the Marfan syndrome.
    Ann Hum Genet. 1972 Mar;35(3):331-6 PMID: 5072691
  5. Risk of dominant mutation in older fathers: evidence from osteogenesis imperfecta.
    J Med Genet. 1986 Jun;23(3):227-30 PMID: 3723550
  6. Missing heritability: paternal age effect mutations and selfish spermatogonia.
    Nat Rev Genet. 2010 Aug;11(8):589 PMID: 20634812
  7. Preferential mutation of the neurofibromatosis type 1 gene in paternally derived chromosomes.
    Hum Genet. 1992 Jan;88(3):279-82 PMID: 1346385
  8. Dear old dad.
    Sci Aging Knowledge Environ. 2004 Jan 21;2004(3):re1 PMID: 14736914
  9. Genetic disease in the offspring of older fathers.
    Obstet Gynecol. 1981 Jun;57(6):745-9 PMID: 7231827
  10. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1.
    J Med Genet. 2007 Feb;44(2):81-8 PMID: 17105749
  11. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications.
    Neurosurg Focus. 2010 Jan;28(1):E8 PMID: 20043723
  12. Neurofibromatosis type 1: review of the first 200 patients in an Australian clinic.
    J Child Neurol. 1993 Oct;8(4):395-402 PMID: 8228039
  13. Statement on guidance for genetic counseling in advanced paternal age.
    Genet Med. 2008 Jun;10(6):457-60 PMID: 18496227
  14. The pathophysiology of neurofibromatosis: IX. Paternal age as a factor in the origin of new mutations.
    Am J Med Genet. 1984 May;18(1):169-76 PMID: 6430086
  15. Down syndrome in live births by single year maternal age interval in a Swedish study: comparison with results from a New York State study.
    Am J Hum Genet. 1978 Jan;30(1):19-27 PMID: 146429
  16. Paternal origin of FGFR2 mutations in sporadic cases of Crouzon syndrome and Pfeiffer syndrome.
    Am J Hum Genet. 2000 Mar;66(3):768-77 PMID: 10712195
  17. Estimated rates of Down syndrome in live births by one year maternal age intervals for mothers aged 20-49 in a New York State study-implications of the risk figures for genetic counseling and cost-benefit analysis of prenatal diagnosis programs.
    Birth Defects Orig Artic Ser. 1977;13(3A):123-41 PMID: 141957
  18. Reproductive functions of the ageing male.
    Hum Reprod Update. 2004 Jul-Aug;10(4):327-39 PMID: 15192059
  19. Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service.
    Am J Med Genet A. 2010 Feb;152A(2):327-32 PMID: 20082463
  20. Gain-of-function amino acid substitutions drive positive selection of FGFR2 mutations in human spermatogonia.
    Proc Natl Acad Sci U S A. 2005 Apr 26;102(17):6051-6 PMID: 15840724
  21. Paternal origin of new mutations in von Recklinghausen neurofibromatosis.
    Nature. 1990 Feb 8;343(6258):558-9 PMID: 2105472
  22. Spontaneous mutation and parental age in humans.
    Am J Hum Genet. 1987 Aug;41(2):218-48 PMID: 3618593
  23. Advanced parental age and the risk of autism spectrum disorder.
    Am J Epidemiol. 2008 Dec 1;168(11):1268-76 PMID: 18945690
  24. Achondroplasia and parental age.
    N Engl J Med. 1986 Feb 20;314(8):521-2 PMID: 3945286
  25. Age-dependent germline mosaicism of the most common noonan syndrome mutation shows the signature of germline selection.
    Am J Hum Genet. 2013 Jun 6;92(6):917-26 PMID: 23726368
  26. Parental age and Neurofibromatosis Type 1: a report from the NF1 Patient Registry Initiative.
    Fam Cancer. 2015 Jun;14(2):317-24 PMID: 25523354
  27. Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children.
    Pediatrics. 2000 Mar;105(3 Pt 1):608-14 PMID: 10699117
  28. Neurofibromatosis in Gothenburg, Sweden. IV. Genetic analyses.
    Neurofibromatosis. 1989;2(2):107-15 PMID: 2516454
  29. Evidence for reduced recombination on the nondisjoined chromosomes 21 in Down syndrome.
    Science. 1987 Aug 7;237(4815):652-4 PMID: 2955519
  30. NF1 gene and neurofibromatosis 1.
    Am J Epidemiol. 2000 Jan 1;151(1):33-40 PMID: 10625171
  31. Paternal age effect mutations and selfish spermatogonial selection: causes and consequences for human disease.
    Am J Hum Genet. 2012 Feb 10;90(2):175-200 PMID: 22325359
  32. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21.
    Cell. 1990 Nov 16;63(4):843-9 PMID: 2121370
  33. Paternal age and sporadic neurofibromatosis 1: a case-control study and consideration of the methodologic issues.
    Genet Epidemiol. 1997;14(5):507-16 PMID: 9358268
  34. Advancing paternal age and risk of autism: new evidence from a population-based study and a meta-analysis of epidemiological studies.
    Mol Psychiatry. 2011 Dec;16(12):1203-12 PMID: 21116277
  35. Neurofibromatosis-1: a maximum likelihood estimation of mutation rate.
    Hum Genet. 1990 Jan;84(2):116-8 PMID: 2105266
  36. The importance of advanced parental age in the origin of neurofibromatosis type 1.
    Am J Med Genet A. 2012 Mar;158A(3):519-23 PMID: 22302476
  37. The origins, patterns and implications of human spontaneous mutation.
    Nat Rev Genet. 2000 Oct;1(1):40-7 PMID: 11262873
  38. Parental age in acondroplasia and mongolism.
    Am J Hum Genet. 1957 Sep;9(3):167-9 PMID: 13507646
  39. A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity.
    J Med Genet. 1989 Nov;26(11):704-11 PMID: 2511318
  40. Paternal age >or=40 years: an important risk factor for infertility.
    Am J Obstet Gynecol. 2003 Oct;189(4):901-5 PMID: 14586322
  41. An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation.
    Am J Hum Genet. 2007 Jan;80(1):140-51 PMID: 17160901
  42. Genetics of neurofibromatosis 1 in Japan: mutation rate and paternal age effect.
    Hum Genet. 1992 May;89(3):281-6 PMID: 1351032
  43. Epidemiology of neurofibromatosis type 1 (NF1) in northern Finland.
    J Med Genet. 2000 Aug;37(8):632-6 PMID: 10991696
Article Info
Journal
Molecular genetics & genomic medicine
Abbr.
Mol Genet Genomic Med
ISSN
2324-9269
Published
2016-07-00
Epub
2016-00-16
Pages
480-6
Language
English
Region
United States
NLM ID
101603758
PMCID
PMC4947867
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]